Time Trade-Off
Cross-source consensus on Time Trade-Off from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Risks & contraindications
Comparisons
Highlighted claims
- The study used time trade-off utility scores as the reference standard for evaluating EQ-5D performance. — Reliability and validity of EuroQol-5 Dimensions-5 Levels in patients with haematologic malignancies: a cross-sectional study in China
- Time trade-off asks patients to choose between 10 years in their current health state and a shorter time in perfect health. — Reliability and validity of EuroQol-5 Dimensions-5 Levels in patients with haematologic malignancies: a cross-sectional study in China
- Time trade-off reflects patients' subjective valuation of their overall health state. — Reliability and validity of EuroQol-5 Dimensions-5 Levels in patients with haematologic malignancies: a cross-sectional study in China
- Acute leukaemia had the highest time trade-off utility among the three groups, while multiple myeloma had the lowest. — Reliability and validity of EuroQol-5 Dimensions-5 Levels in patients with haematologic malignancies: a cross-sectional study in China
- Time trade-off has limitations because it requires complex hypothetical trade-offs involving time and health states. — Reliability and validity of EuroQol-5 Dimensions-5 Levels in patients with haematologic malignancies: a cross-sectional study in China